Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...

"It has been an exciting start," Solventum CEO Bryan Hanson said of the 3M Health Care spinoff's first two quarters.

Baxter expects to lose out on at least $200 million worth of sales due to Hurricane Helene's flooding at its North Cove ...

Insulet (Nasdaq:PODD) once again posted significant year-over-year growth as Omnipod revenues continue to rise.

Johnson & Johnson MedTech announced today that the FDA approved its Varipulse pulsed field ablation (PFA) platform for ...

BD (NYSE:BDX) shares ticked up before hours today on fourth-quarter results that came in ahead of the consensus forecast.

Zeta Surgical announced that the FDA granted 510(k) clearance for its Zeta Navigation System for expanded capabilities.

Precision Neuroscience, which is developing a minimally invasive brain implant, hoped to raise up to $150 million in its ...

Corin announced that it received FDA 510(k) clearance for its Icona femoral stem implant for total hip arthroplasty (THA).

Stereotaxis said physicians at the University of Kansas Health System successfully treated the first patients with its ...

Endologix announced final 36-month results for the DETOUR2 study evaluating its Detour system for treating peripheral ...

Masimo (Nasdaq:MASI) shares ticked up before hours today on third-quarter results that came in ahead of the consensus ...